| Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and … Y Inamoto, N Valdés-Sanz, Y Ogawa, M Alves, L Berchicci, J Galvin, ... Bone marrow transplantation 54 (5), 662-673, 2019 | 89 | 2019 |
| Incidence, risk factors for and outcomes of transplant‐associated thrombotic microangiopathy N Epperla, A Li, B Logan, C Fretham, S Chhabra, M Aljurf, L Chee, ... British journal of haematology 189 (6), 1171-1181, 2020 | 75 | 2020 |
| Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure SM Smith, J Godfrey, KW Ahn, A DiGilio, S Ahmed, V Agrawal, ... Cancer 124 (12), 2541-2551, 2018 | 75 | 2018 |
| Survival following allogeneic transplant in patients with myelofibrosis K Gowin, K Ballen, KW Ahn, ZH Hu, H Ali, MO Arcasoy, R Devlin, ... Blood advances 4 (9), 1965-1973, 2020 | 70 | 2020 |
| Age no bar: a CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma PN Munshi, D Vesole, A Jurczyszyn, JM Zaucha, A St. Martin, O Davila, ... Cancer 126 (23), 5077-5087, 2020 | 55 | 2020 |
| Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages S Feurstein, AM Trottier, N Estrada-Merly, M Pozsgai, K McNeely, ... Blood, The Journal of the American Society of Hematology 140 (24), 2533-2548, 2022 | 54 | 2022 |
| Composite GRFS and CRFS outcomes after adult alternative donor HCT RS Mehta, SG Holtan, T Wang, MT Hemmer, SR Spellman, M Arora, ... Journal of Clinical Oncology 38 (18), 2062, 2020 | 43 | 2020 |
| Risk factors for graft-versus-host disease in haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide A Im, A Rashidi, T Wang, M Hemmer, ML MacMillan, J Pidala, M Jagasia, ... Biology of blood and marrow transplantation 26 (8), 1459-1468, 2020 | 42 | 2020 |
| Characteristics of late fatal infections after allogeneic hematopoietic cell transplantation M Norkin, BE Shaw, R Brazauskas, HR Tecca, HL Leather, ... Biology of blood and marrow transplantation 25 (2), 362-368, 2019 | 41 | 2019 |
| Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis M Hamadani, AK Gopal, M Pasquini, S Kim, X Qiu, S Ahmed, A Lazaryan, ... Blood advances 6 (2), 486-494, 2022 | 28 | 2022 |
| Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by … A Lazaryan, M Dolan, MJ Zhang, HL Wang, MA Kharfan-Dabaja, DI Marks, ... haematologica 105 (5), 1329, 2020 | 28 | 2020 |
| T-cell acute lymphoblastic leukemia—current concepts in molecular biology and management P Shiraz, W Jehangir, V Agrawal Biomedicines 9 (11), 1621, 2021 | 25 | 2021 |
| Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant … Y Inamoto, I Petriček, L Burns, S Chhabra, Z DeFilipp, P Hematti, A Rovó, ... Bone marrow transplantation 54 (5), 648-661, 2019 | 22 | 2019 |
| Allogeneic transplantation to treat therapy-related myelodysplastic syndrome and acute myelogenous leukemia in adults L Metheny, NS Callander, AC Hall, MJ Zhang, K Bo-Subait, HL Wang, ... Transplantation and cellular therapy 27 (11), 923. e1-923. e12, 2021 | 20 | 2021 |
| Reduced intensity conditioning for acute myeloid leukemia using melphalan-vs busulfan-based regimens: a CIBMTR report Z Zhou, R Nath, J Cerny, HL Wang, MJ Zhang, H Abdel-Azim, V Agrawal, ... Blood advances 4 (13), 3180-3190, 2020 | 18 | 2020 |
| Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases JM Kahn, R Brazauskas, HR Tecca, S Bo-Subait, D Buchbinder, ... Blood advances 4 (9), 2084-2094, 2020 | 18 | 2020 |
| Survival trends in infants undergoing allogeneic hematopoietic cell transplant SH Parikh, P Satwani, KW Ahn, NA Sahr, C Fretham, AA Abraham, ... JAMA pediatrics 173 (5), e190081-e190081, 2019 | 18 | 2019 |
| Impact of induction therapy with VRD versus VCD on outcomes in patients with multiple myeloma in partial response or better undergoing upfront autologous stem cell transplantation S Sidana, S Kumar, R Fraser, N Estrada-Merly, S Giralt, V Agrawal, ... Transplantation and cellular therapy 28 (2), 83. e1-83. e9, 2022 | 17 | 2022 |
| Adverse health outcomes among US testicular cancer survivors after cisplatin-based chemotherapy vs surgical management V Agrawal, PC Dinh Jr, C Fung, PO Monahan, SK Althouse, K Norton, ... JNCI cancer spectrum 4 (2), pkz079, 2020 | 17 | 2020 |
| Staging systems for newly diagnosed myeloma patients undergoing autologous hematopoietic cell transplantation: the revised international staging system shows the most … EC Scott, P Hari, S Kumar, R Fraser, O Davila, N Shah, RP Gale, MA Diaz, ... Biology of Blood and Marrow Transplantation 24 (12), 2443-2449, 2018 | 17 | 2018 |
